BSE: 524520 | NSE: | Hospital & Healthcare Services | Small Cap
Past 10 year's financial track record analysis by Moneyworks4me indicates that KMC Speciality Hospitals (India) Ltd is a good quality company.
The key valuation ratios of KMC Speciality Hospitals (India) Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of KMC Speciality Hospitals (India) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 4.3% | 6% | 18.3% | 23.4% | 19.6% | 20.3% | 23.3% | 18.3% | 23.9% | 20.3% | - |
| Value Creation Index ⓘ | -0.7 | -0.6 | 0.2 | 0.6 | 0.3 | 0.4 | 0.6 | 0.2 | NA | NA | - |
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ | |||||||||||
| Sales ⓘ | 31.9 | 36.3 | 42.6 | 54.8 | 70.7 | 82.3 | 96.2 | 103 | 136 | 156 | 173 |
| Sales YoY Gr. | - | 13.8% | 17.3% | 28.8% | 28.9% | 16.4% | 16.9% | 6.7% | 32.6% | 14.5% | - |
| Adj EPS ⓘ | -0 | 0 | 0.2 | 0.3 | 0.4 | 0.5 | 0.7 | 0.8 | 1.5 | 1.6 | 1.9 |
| YoY Gr. | - | NA | 1900% | 65% | 24.2% | 29.3% | 35.9% | 8.3% | 85.9% | 13.1% | - |
| BVPS (₹) ⓘ | 0.6 | 0.6 | 0.8 | 1.5 | 1.9 | 2.4 | 3.1 | 3.9 | 5.3 | 7 | 8.4 |
| Adj Net Profit ⓘ | -0.4 | 0.1 | 3.2 | 5.4 | 6.7 | 8.6 | 11.7 | 12.8 | 23.7 | 26.8 | 30 |
| Cash Flow from Ops. ⓘ | 3.9 | 5.4 | 5.7 | 10.1 | 12.4 | 15.8 | 10.7 | 25.6 | 29.1 | 32.3 | - |
| Debt/CF from Ops. ⓘ | 4.2 | 2.5 | 1.8 | 0.6 | 1.2 | 0.7 | 0.7 | 1.1 | 0.9 | 1.4 | - |
CAGR Colour Code Guide ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 19.3% | 17.1% | 17.4% | 14.5% | ||||
| Adj EPS ⓘ | NA | 32% | 31.6% | 13.1% | ||||
| BVPSⓘ | 30.8% | 30.2% | 30.8% | 30.8% | ||||
| Share Price | 46.5% | 47.4% | 38.4% | 48.4% | ||||
Performance Ratio Colour Code Guide ⓘ
| Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -3.1 | 1 | 27.2 | 28.6 | 24.6 | 24.8 | 26.2 | 22.4 | 31.6 | 26.7 | 24.4 |
| Op. Profit Mgn % ⓘ | 5.3 | 15.8 | 18.9 | 22.8 | 20.4 | 19.8 | 22.2 | 22.3 | 27.4 | 26.6 | 27 |
| Net Profit Mgn % ⓘ | -1.1 | 0.3 | 7.6 | 9.8 | 9.5 | 10.5 | 12.2 | 12.4 | 17.4 | 17.2 | 17.6 |
| Debt to Equity ⓘ | 1.6 | 1.3 | 0.8 | 0.3 | 0.5 | 0.3 | 0.2 | 0.4 | 0.3 | 0.4 | - |
| Working Cap Days ⓘ | 47 | 48 | 50 | 47 | 40 | 49 | 84 | 101 | 86 | 111 | 55 |
| Cash Conv. Cycle ⓘ | -6 | -15 | -14 | -12 | -11 | -15 | -11 | -7 | -7 | -5 | 29 |
Sales growth is growing at healthy rate in last 3 years 17.43%
Net Profit is growing at healthy rate in last 3 years 31.57%
Sales growth is good in last 4 quarters at 18.04%
Return on Equity has declined versus last 3 years average to 24.40%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 1.9 | - |
| TTM Sales (₹ Cr.) | 173 | - |
| BVPS (₹.) ⓘ | 8.4 | - |
| Reserves (₹ Cr.) ⓘ | 120 | - |
| P/BV ⓘ | 10.92 | - |
| PE ⓘ | 48.87 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 58.50 / 104.95 |
| All Time Low / High (₹) | 0.07 / 104.95 |
| Market Cap (₹ Cr.) | 1,493 |
| Equity (₹ Cr.) | 16.3 |
| Face Value (₹) | 1 |
| Industry PE ⓘ | 85.2 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 32 | 36 | 43 | 55 | 71 | 82 | 96 | 103 | 136 | 156 |
| Operating Expenses ⓘ | 30 | 31 | 35 | 42 | 56 | 66 | 75 | 80 | 99 | 114 |
| Manufacturing Costs | 12 | 13 | 15 | 18 | 23 | 28 | 31 | 34 | 43 | 50 |
| Material Costs | 6 | 6 | 7 | 9 | 10 | 12 | 14 | 16 | 21 | 23 |
| Employee Cost | 8 | 9 | 10 | 12 | 16 | 17 | 22 | 22 | 27 | 31 |
| Other Costs ⓘ | 4 | 2 | 3 | 4 | 7 | 9 | 8 | 8 | 8 | 10 |
| Operating Profit ⓘ | 2 | 6 | 8 | 12 | 14 | 16 | 21 | 23 | 37 | 41 |
| Operating Profit Margin (%) | 5.3% | 15.8% | 18.9% | 22.8% | 20.3% | 19.8% | 22.2% | 22.3% | 27.4% | 26.5% |
| Other Income ⓘ | 3 | 0 | 1 | 0 | 0 | 2 | 1 | 3 | 2 | 3 |
| Interest ⓘ | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation ⓘ | 4 | 4 | 3 | 3 | 4 | 4 | 5 | 6 | 7 | 8 |
| Exceptional Items ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax ⓘ | -2 | 0 | 4 | 8 | 10 | 12 | 17 | 18 | 32 | 36 |
| Tax ⓘ | -1 | 0 | 1 | 3 | 3 | 4 | 5 | 5 | 8 | 9 |
| Profit After Tax | 0 | 0 | 3 | 5 | 7 | 9 | 12 | 13 | 24 | 27 |
| PAT Margin (%) | -0.9% | 0.3% | 7.5% | 9.8% | 9.4% | 10.5% | 12.2% | 12.5% | 17.4% | 17.1% |
| Adjusted EPS (₹) | 0.0 | 0.0 | 0.2 | 0.3 | 0.4 | 0.5 | 0.7 | 0.8 | 1.5 | 1.6 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | ||||||||||
| Shareholders Fund | 10 | 10 | 13 | 24 | 30 | 39 | 51 | 63 | 87 | 114 |
| Share Capital ⓘ | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves ⓘ | -6 | -6 | -3 | 8 | 14 | 23 | 34 | 47 | 70 | 97 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt | 13 | 10 | 7 | 3 | 11 | 8 | 6 | 27 | 20 | 40 |
| Long Term Debt | 12 | 9 | 6 | 3 | 10 | 8 | 6 | 26 | 20 | 40 |
| Short Term Debt | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
| Trade Payables | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 5 | 6 |
| Others Liabilities ⓘ | 7 | 7 | 6 | 2 | 3 | 4 | 19 | 24 | 40 | 54 |
| Total Liabilities ⓘ | 33 | 31 | 29 | 33 | 49 | 56 | 80 | 120 | 152 | 214 |
Fixed Assets | ||||||||||
| Gross Block | 43 | 44 | 44 | 28 | 43 | 47 | 55 | 95 | 102 | 118 |
| Accumulated Depreciation | 15 | 19 | 22 | 3 | 7 | 11 | 16 | 21 | 27 | 34 |
| Net Fixed Assetsⓘ | 28 | 25 | 23 | 24 | 36 | 36 | 39 | 74 | 75 | 84 |
| CWIP ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 6 | 34 |
| Investmentsⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventories | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Trade Receivables | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 4 |
| Cash Equivalents | 0 | 0 | 0 | 1 | 4 | 6 | 10 | 18 | 33 | 39 |
| Others Assetsⓘ | 3 | 3 | 4 | 5 | 5 | 11 | 26 | 22 | 33 | 51 |
| Total Assets ⓘ | 33 | 31 | 29 | 33 | 49 | 56 | 80 | 120 | 152 | 214 |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ | 4 | 5 | 6 | 10 | 12 | 16 | 11 | 26 | 29 | 32 |
| PBT ⓘ | -2 | 0 | 4 | 8 | 10 | 12 | 12 | 18 | 32 | 36 |
| Adjustment ⓘ | 4 | 6 | 4 | 5 | 6 | 5 | 10 | 7 | 6 | 7 |
| Changes in Working Capital ⓘ | 3 | 1 | -1 | -1 | -1 | 1 | -8 | 3 | -0 | -2 |
| Tax Paid ⓘ | -1 | -1 | -2 | -2 | -2 | -3 | -3 | -3 | -9 | -9 |
| Cash Flow From Investing Activity ⓘ | -2 | -1 | -1 | -4 | -19 | -9 | -8 | -43 | -29 | -48 |
| Capex | -2 | -1 | -1 | -4 | -16 | -3 | -3 | -41 | -13 | -44 |
| Net Investments | 0 | 0 | 0 | 0 | -3 | -1 | -4 | -7 | -16 | -6 |
| Others ⓘ | 0 | 0 | 0 | 0 | 0 | -4 | 0 | 5 | 1 | 2 |
| Cash Flow From Financing Activityⓘ | -1 | -5 | -5 | -5 | 6 | -5 | -4 | 18 | -1 | 16 |
| Net Proceeds from Shares ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Proceeds from Borrowing ⓘ | 1 | -3 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 18 |
| Interest Paid ⓘ | -2 | -2 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 |
| Dividend Paid ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others ⓘ | 0 | 0 | 0 | -4 | 7 | -4 | -3 | 19 | -1 | -1 |
| Net Cash Flow ⓘ | 0 | 0 | 0 | 1 | -1 | 1 | -1 | 1 | 0 | 0 |
| PARTICULARS | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | -2.52 | 1.22 | 27.24 | 28.6 | 24.43 | 24.78 | 26.17 | 22.42 | 31.61 | 26.65 |
| ROCE (%) | 2.37 | 8.53 | 23.92 | 34.73 | 28.63 | 29.11 | 33.09 | 25.85 | 32.44 | 27.32 |
| Asset Turnover Ratio | 0.94 | 1.13 | 1.41 | 1.76 | 1.73 | 1.57 | 1.41 | 1.03 | 1 | 0.85 |
| PAT to CFO Conversion(x) | N/A | N/A | 2 | 2 | 1.71 | 1.78 | 0.92 | 2 | 1.21 | 1.19 | Working Capital Days |
| Receivable Days | 13 | 11 | 12 | 11 | 11 | 9 | 7 | 8 | 8 | 9 |
| Inventory Days | 8 | 7 | 6 | 4 | 3 | 4 | 6 | 7 | 5 | 5 |
| Payable Days | 146 | 168 | 156 | 130 | 128 | 143 | 127 | 107 | 94 | 94 |
KMC Speciality Hospital (I), formerly Seahorse Hospitals Ltd is a renowned hospital situated in Trichy was incorporated in 1999. The hospital boasts of a 24-hour cardiac care with facilities comparable to metropolitan cities like Chennai, Bangalore, Mumbai, etc.
KMC hospital, in its decennial year of operations has added numerous feathers to its cap.From a humble beginning of 30 beds in 1999 it has come a long way to 400 beds by acquiring Seahorse Hospital. The number of doctors in the hospital has grown from 10 to 100 and the satff members have grown to over 1000.
Seahorse hospital management was taken over by KMC by the end of February 2008 .Now all the procedural formalities have been completed and hence forth it will be called as KMC Speciality Hospital, has came into effect from December 12 2008. KMC Group of Hospitals is planning to invest further Rs.10 crore to upgrade all the existing facilities.
To reaffirm the high level of healthcare which they are providing, they have started the accreditaion process for National Accreditaion Board for Hospital (NABH) and for National Accreditaion Board for Laboratories (NABL). The hospital has full time consultants in all the basic specialties. Especially Obstetrics & Gynaecology, Paediatrics, Cardiology, ENT, Dental, Joint Replacement, Plastic Surgery, Neurology, diabetology, etc. The hospital will be starting infertility Management very soon.
KMC Speciality Hospitals (I) has an out patient department exclusively like Coronary artery disease clinic, Pediatric Cardiology, Vascular Heart disease clinic, Arrhythmia Clinic, Cardiovascular surgery department.
KMC Speciality Hospitals (I) , offers a comprehensive cardiac health check up scheme called 'Healthy Heart'.This includes a detailed cardiac examination by physicians and cardiologist followed by a wide range of investigations that include blood tests, to check for diabetes, high cholesterol and kidney disease, urine tests, ECG, Echo 2D etc.
Services offered by the company :
Specialties services:
Other services:
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
